Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder

Addiction(2023)10.1111/add.16334Source: DataRank Database

Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder is a research paper published in Addiction (2023). On theSindex it has a DataRank of 0.507. It has been cited 13 times, with 13 citing works in its 1-hop citation network.

N/A

0.507DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access13 citations · 13 citing works in its network

Download PDF

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02032433 NCT03275350

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.14)OA: bronzeTopics (49)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 78%Citation Network 22%

Base Score Contribution

0.396

From this paper's citation signal

Citation Network Contribution

0.111

From 6 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 13 citers.

Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens
JAMA Network Open202417 citations60 referencesContributes 0.048
Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial
Drug and Alcohol Dependence20251 citations26 referencesContributes 0.027
Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs
JAMA Health Forum20254 citations83 referencesContributes 0.019
Co-Morbid Use and Misuse of Opioids and Stimulants: Clinical Neurobiology
Current Addiction Reports20252 citations61 referencesContributes 0.018
Baseline Characteristics and Postdischarge Outcomes by Medication for Opioid Use Disorder Status Among Women with Polysubstance Use in Residential Treatment
Women s Health Reports20231 citations40 referencesContributes 0.017

Authors (6)

P. Todd Korthuis ORCID,Judith I. Tsui ORCID,Sean X. Luo ORCID,Brian Chan ORCID,Ryan Cook ORCID

Live enrichment

PubMed:37712113 OpenAlex:https://openalex.org/W4386757551

National Institute on Drug Abuse

Grant: K01DA055130

National Institute on Drug Abuse

Grant: UG1DA015831

NIDA NIH HHS

Grant: UG1 DA013714

AHRQ HHS

Grant: K12 HS026370

NIDA NIH HHS

Grant: K23 DA053390

NIDA NIH HHS

Grant: L30 DA054663

FWCI

3.14

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.16334

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/add.16334

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/add.16334

journalhttps://doi.org/10.1111/add.16334

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37712113

Fields of Study

Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual RiskFemaleHumansMaleAnalgesics, OpioidBuprenorphineCentral Nervous System StimulantsDelayed-Action PreparationsNaltrexoneOpioid-Related DisordersRecurrenceUnited StatesAdultMiddle AgedClinical Trials as Topic

MeSH Terms

Buprenorphine, Naloxone Drug CombinationAdultCentral Nervous System StimulantsAnalgesics, OpioidBuprenorphineClinical Trials as TopicDelayed-Action PreparationsFemaleHumansMaleMiddle AgedNaltrexoneNarcotic AntagonistsOpioid-Related DisordersRecurrenceUnited States

Keywords

Opioid use disorderStimulantMedicineNaltrexoneBuprenorphineOpioidConfidence intervalHazard ratioSubstance abusePsychiatryInternal medicineextended-release naltrexonemedications for opioid use disorderopioidsrelapsestimulants

Sustainable Development Goals

SDG 0: Good health and well-being